July 27, 2020

InSysBio announces its participation in AAIC 2020 Virtual Event. Alzheimer’s Association International Conference is held virtually on July 27-31. InSysBio team presents two posters within its frames, namely:

Monday, July 27, 12:00 AM - 11:59 PM (CDT)

• Poster #42926
  “Description of amyloid beta influence on synaptic plasticity and tau hyperphosphorylation by mechanistic quantitative systems pharmacology model” by Stepan Lerner, Tatiana Karelina

Wednesday, July 29, 12:00 AM - 11:59 PM (CDT)

• Poster #42695
  “Quantitative systems pharmacology model of Alzheimer’s disease to study efficacy of combinatorial therapy on multiple pathology components” by Tatiana Karelina

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

Share